Clinical Trial Update: Metastatic Gastric Cancer FFCD 03-07 [Phase 3]

View source ↗

Summary

Phase 3 trial FFCD 03-07 evaluating metastatic gastric cancer has completed its study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Stomach Cancer, Neoplasm Metastasis | Phase 3 | Status: COMPLETED